Acciones Callitas Health Inc. Deutsche Boerse AG
Acciones
T3F3
CA13125C1068
Biotecnología e investigación médica
Ventas 2018 | 0,75 0,7 | Ventas 2019 | 0,71 0,66 | Capitalización | 3,53 M 3,31 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -4,69 M | Resultado Neto 2019 | -1 M -938 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 299 mil | Deuda neta 2019 | 848 mil 795 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+0,17 % | 42,19 mil M | |
+10,92 % | 42,24 mil M | |
+44,30 % | 40,15 mil M | |
-6,20 % | 28,31 mil M | |
+5,23 % | 24,63 mil M | |
-24,79 % | 18,2 mil M | |
+26,69 % | 12,01 mil M | |
-3,13 % | 11,76 mil M | |
+6,57 % | 10,4 mil M |